Myeloperoxidase modulates lung epithelial responses to pro-inflammatory agents

Haegens A., Vernooy J. H. J., Heeringa P., Mossman B. T., Wouters E. F. M.

Source: Eur Respir J 2008; 31: 252-260
Journal Issue: February
Disease area: Airway diseases

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Haegens A., Vernooy J. H. J., Heeringa P., Mossman B. T., Wouters E. F. M.. Myeloperoxidase modulates lung epithelial responses to pro-inflammatory agents. Eur Respir J 2008; 31: 252-260

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Alveolar macrophage oxidative and pro-inflammatory cytokine activity in lung sarcoidosis
Source: Eur Respir J 2005; 26: Suppl. 49, 332s
Year: 2005

Contribution of myeloperoxidase to inflammatory processes in lung epithelial cells
Source: Eur Respir J 2006; 28: Suppl. 50, 853s
Year: 2006

iNOS inhibition modulates lung tissue inflammation via oxidative stress pathway activation
Source: Annual Congress 2008 - Inflammatory trigger mechanisms in asthma and COPD
Year: 2008


Airway inflammation: assessment of neutrophil apoptosis in induced sputum
Source: Annual Congress 2005 - Acute and chronic infections in COPD
Year: 2005


Physical stress modulates distal lung tissue mechanics, inflammation and remodelling associated to iNOS and oxidative stress activation
Source: Annual Congress 2008 - Pathophysiology of respiratory diseases
Year: 2008


Amifostine reduces lipopolysaccharide-induced lung dysfunction via suppression of redox-sensitive inflammatory signaling
Source: Annual Congress 2008 - Animal models of pulmonary fibrosis: mechanisms and therapies
Year: 2008


Amifostine reduces lung vascular permeability via suppression of inflammatory signalling
Source: Eur Respir J 2009; 33: 612-624
Year: 2009



Direct evidence of secondary necrosis of neutrophils during intense lung inflammation
Source: Eur Respir J 2006; 28: 268-274
Year: 2006



Aerobic training inhibits leukocytes production of oxidants, pro-inflammatory and pro-fibrotic factors reducing asthmatic phenotype
Source: Annual Congress 2012 - Cell culture and animal models of lung disease
Year: 2012


Extracellular Hsp70 alters cigarette smoke-induced pro-inflammatory responses in human macrophages
Source: International Congress 2018 – Translational models of the immunopathology that underlies airway obstructive diseases
Year: 2018


Development of new treatments for complex chronic comorbidities
Source: Research Seminar 2006 - Complexity of patients with multiple chronic diseases
Year: 2006



Inflammatory response to infectious pulmonary injury
Source: Eur Respir J 2003; 22: 10S-14S
Year: 2003



Carbonyl stress and enhanced macrophage function
Source: Annual Congress 2005 - Oxidative and nitrative stress: control of cell function in COPD
Year: 2005

Neutrophil airway influx by platelet-activating factor in asthma: role of adhesion molecules and LTB4 expression
Source: Eur Respir J 2003; 22: 290-297
Year: 2003



Increased lung neutrophil apoptosis and inflammation resolution
Source: Eur Respir J 2012; 39: 790-791
Year: 2012


Increased lung neutrophil apoptosis and inflammation resolution
Source: Eur Respir J 2012; 39: 789-790
Year: 2012


Chronic inflammation in asthma
Source: ISSN=1025-448x, ISBN=1-904097-26-x, page=126
Year: 2003

Cells and mediators of chronic obstructive pulmonary disease
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-48-0, page=130
Year: 2006

Arginine levels regulate pro-inflammatory mediator responses by lung epithelial cells
Source: Eur Respir J 2005; 26: Suppl. 49, 554s
Year: 2005